Ionis Pharmaceuticals IONS Debt Securities Available For Sale And Equity Securities Fv Ni Cost
Debt Securities Available For Sale And Equity Securities Fv Ni Cost at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiCost.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni cost?
- Ionis Pharmaceuticals (IONS) reported debt securities available for sale and equity securities fv ni cost of $1.77B in Q1 2026.
- How has Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni cost changed year-over-year?
- Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni cost decreased by 9.1% year-over-year, from $1.95B to $1.77B.
- What is the long-term trend for Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni cost?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni cost has grown at a 9.1% compound annual growth rate (CAGR), from $1.53B to $2.37B.
- What does debt securities available for sale and equity securities fv ni cost mean?
- The total original cost of all debt and equity investments held by the company.
- How do you interpret debt securities available for sale and equity securities fv ni cost?
- An increase indicates a larger capital commitment to investment assets, reflecting either cash accumulation or strategic investment growth.
- How does debt securities available for sale and equity securities fv ni cost compare across companies?
- Used by analysts to evaluate the total size of the company's investment engine.